OLIGOMETASTATIC DISEASE
Clinical trials for OLIGOMETASTATIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC DISEASE trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug combo trial halted early – only 6 patients enrolled
Disease control TerminatedThis study tested a new treatment for people with non-small cell lung cancer or kidney cancer that had spread to a few spots (oligometastatic). The treatment combined precise radiation (PULSAR) with immunotherapy drugs (pembrolizumab or nivolumab), plus an experimental drug calle…
Matched conditions: OLIGOMETASTATIC DISEASE
Phase: PHASE2 • Sponsor: ImmuneSensor Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
Pancreatic cancer surgery trial ends early – only 5 patients enrolled
Disease control TerminatedThis study looked at whether surgically removing small tumors in the liver or lungs (called oligometastases) could help people with pancreatic cancer live longer. All participants had already received chemotherapy before surgery. The trial was stopped early after enrolling only 5…
Matched conditions: OLIGOMETASTATIC DISEASE
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Shorter, cheaper liver scan could spot cancer spread just as well
Diagnosis TerminatedThis study tested whether a shorter, less expensive liver MRI using one contrast agent works as well as the standard agent for finding colorectal cancer that has spread to the liver. Ten adults with suspected liver metastases were enrolled. The goal was to see if the faster metho…
Matched conditions: OLIGOMETASTATIC DISEASE
Phase: PHASE4 • Sponsor: University of Colorado, Denver • Aim: Diagnosis
Last updated May 14, 2026 12:04 UTC